Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, retailers and other industry players look to expand their businesses and gain a competitive edge. Here’s a roundup of new deals that were revealed, closed, rumored or called off during the month of November.
Providers
The West Virginia University Health System is poised to absorb the five-hospital Independence Health System by fall 2026. The deal is subject to regulatory reviews and bondholder consent and includes Independence’s affiliated physician groups and other subsidiaries. In exchange, WVU Health System committed to a five-year, $800 million investment to expand Independence’s clinical services and modernize facilities.
Community Health Systems is selling its 80% interests in two Tennessee joint ventures related to Tennova Healthcare – Clarksville, a 270-bed hospital, to Vanderbilt University Medical Center, which already owns the remaining 20% interests. The $600 million deal is expected to close in early 2026 pending regulatory approvals and closing conditions.
Premier Inc., a healthcare group purchasing, technology and intelligence company, was taken private as an affiliate of healthcare investment firm Patient Square Capital in a $2.6 billion deal, for which stockholders received $28.25 per share in cash. Premier has been public since 2013 and counts more than two-thirds of all U.S. healthcare providers among its customer base, with $84 billion in group purchasing power and more than 3,000 active negotiated contracts. The go-private was announced in September.
Fairfield Medical Center signed a nonbinding letter of intent to explore affiliating with OhioHealth. Potential terms of that arrangement or a timeline were not shared, though the independent medical center said joining up would provide long-term stability and expanded services.
Union Health received the certificate of public advantage from Indiana regulators necessary to acquire the 278-bed Terre Haute Regional Hospital from HCA Healthcare. The application had been submitted in February and faced substantial pushback, including from the Federal Trade Commission.
Parkview Health has signed a strategic agreement to offload parts of its nonemergent outreach laboratory services to Labcorp. The deal is expected to close in 2026 and will kick off a partnership in which patients will gain access to Labcorp’s national network of services.
Prime Healthcare Foundation received conditional approval from Maine regulators to acquire the financially struggling Central Maine Healthcare. The deal was announced near the top of the year and, under the state’s green light, will require Prime to maintain the acquiree’s hospitals and their services for at least five years and to provide audited financial statements annually for three years.
Payers
Cambia Health Solutions and Arkansas Blue Cross and Blue Shield announced a signed definitive agreement to form a strategic affiliation. The Blues said the alliance would join complementary capabilities, operations teams and tech platforms to serve local members. The deal is subject to regulatory approval in Arkansas but is expected to close next year.
Independent Health is set to acquire MVP Health Care under a to-be-approved affiliation deal between the nonprofit plans. Following a deal, the pair would serve nearly a million members in New York and Vermont and control $7 billion in annual revenue.
Medica has signed a definitive agreement to acquire certain contracts and assets from UCare as the latter terminates its Minnesota Medicare Advantage contracts. More than 300,000 members in Minnesota and western Wisconsin would be transferred, with eligible individuals being able to choose whether they would like to enroll in coverage offered by either company for the 2026 plan year. The deal is expected to close in the first quarter of 2026.
Tech
GE HealthCare plans to pay $2.3 billion in cash to acquire imaging software developer Intelerad. The move pushes GE toward its goal of building a cloud-first diagnostic ecosystem that can tap into ambulatory, teleradiology and hospital settings. GE HealthCare estimates Intelerad will bring in about $270 million during its first year, with about 90% attributed to recurring sales among a customer base of more than 1,500 international healthcare organizations. That includes managing more than 230 million exams per year and over 8 billion medical images.
Fabric, a healthcare tech and care enablement company, is acquiring UCM Digital Health in a deal that adds 400 new payer and employer customers and 1 million covered lives. The pickup is Fabric’s fifth in less than three years and will see the company integrate its AI-enabled virtual care technology and nationwide clinical network with UCM’s deep expertise in serving payers and employers. Financial terms were not disclosed.
R1, a revenue cycle management vendor, sold mobile intake and payments platform Tonic Health to Luma Health. The patient engagement platform said its new pickup will support its growth and doubles down on its commitment to customer health systems on Oracle Health’s electronic health record system. Financial terms were not disclosed.
MedEvolve, an AI revenue cycle company, has been acquired by Emergence Software, an equity firm backed by The Pritzker Organization that targets and grows software companies. MedEvolve said the deal will help support its proprietary platform and offer new investments in data science, automation and AI-driven analytics.
Get Well, a patient engagement software company, and RhythmX AI, a precision care company, merged to form a single entity, called GW RhythmX. Both were part of SymphonyAI Group.
LifeMD, a virtual care services and pharmacy company, divested its 80% interest in WorkSimpli Software for about $22 million in cash, with an additional $28 million possible should the company reach growth and operational targets within three years. WorkSimpli founder and CEO Sean Fitzpatrick and a private investment group were the purchasers.
Optain Health, an AI retinal screening technology startup, acquired EyePACS to add its teleophthalmology network and expand access to eye disease screening in primary care. Financial terms of the deal were not disclosed.